Medpace Holdings Inc logo

01P - Medpace Holdings Inc Share Price

€105 3.0  2.9%

Last Trade - 6:55pm

Large Cap
Market Cap £3.29bn
Enterprise Value £3.16bn
Revenue £670.9m
Position in Universe 199th / 1040
Unlock 01P Revenue
Relative Strength (%)
1m +18.9%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -3.77%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
326.4 359.1 421.6 436.2 704.6 861 903.4 1,106 +21.4%
+65.6 +116.8 +35.2 +47.4 +15.3
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Medpace Holdings Inc revenues increased 5% to $435.9M. Net income applicable to common stockholders increased 14% to $52.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Amortization decrease of 55% to $4M (expense), Interest expense, net decrease of 100% to $5K (expense), Miscellaneous (expense) income.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


01P Revenue Unlock 01P Revenue

Net Income

01P Net Income Unlock 01P Revenue

Normalised EPS

01P Normalised EPS Unlock 01P Revenue

PE Ratio Range

01P PE Ratio Range Unlock 01P Revenue

Dividend Yield Range

01P Dividend Yield Range Unlock 01P Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
01P EPS Forecasts Unlock 01P Revenue
Profile Summary

Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated February 18, 2014
Public Since August 11, 2016
No. of Shareholders: n/a
No. of Employees: 3,400
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange Frankfurt Stock Exchange
Shares in Issue 35,408,120
Free Float (0.0%)
Eligible for
01P Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for 01P
Upcoming Events for 01P
Frequently Asked Questions for Medpace Holdings Inc
What is the Medpace Holdings Inc share price?

As of 6:55pm, shares in Medpace Holdings Inc are trading at €105, giving the company a market capitalisation of £3.29bn. This share price information is delayed by 15 minutes.

How has the Medpace Holdings Inc share price performed this year?

Shares in Medpace Holdings Inc are currently trading at €105 and the price has moved by 49.3% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Medpace Holdings Inc price has moved by 55.34% over the past year.

What are the analyst and broker recommendations for Medpace Holdings Inc?

There are no analysts currently covering Medpace Holdings Inc.

When will Medpace Holdings Inc next release its financial results?

Medpace Holdings Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Medpace Holdings Inc dividend yield?

Medpace Holdings Inc does not currently pay a dividend.

Does Medpace Holdings Inc pay a dividend?

Medpace Holdings Inc does not currently pay a dividend.

When does Medpace Holdings Inc next pay dividends?

Medpace Holdings Inc does not currently pay a dividend.

How do I buy Medpace Holdings Inc shares?

To buy shares in Medpace Holdings Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Medpace Holdings Inc?

Shares in Medpace Holdings Inc are currently trading at €105, giving the company a market capitalisation of £3.29bn.

Where are Medpace Holdings Inc shares listed? Where are Medpace Holdings Inc shares listed?

Here are the trading details for Medpace Holdings Inc:

Country of listing: Germany
Exchange: FRA
Ticker Symbol: 01P
What kind of share is Medpace Holdings Inc?

Based on an overall assessment of its quality, value and momentum, Medpace Holdings Inc is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Medpace Holdings Inc share price forecast 2020?

Shares in Medpace Holdings Inc are currently priced at €105. At that level they are trading at 2.25% premium to the analyst consensus target price of 0.00.

Analysts covering Medpace Holdings Inc currently have a consensus Earnings Per Share (EPS) forecast of 3.93 for the next financial year.

How can I tell whether the Medpace Holdings Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medpace Holdings Inc. Over the past six months, the relative strength of its shares against the market has been 42.14%. At the current price of €105, shares in Medpace Holdings Inc are trading at 31.38% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Medpace Holdings Inc PE Ratio?

The Medpace Holdings Inc PE ratio based on its reported earnings over the past 12 months is 42.92. The shares are currently trading at €105.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Medpace Holdings Inc?

Medpace Holdings Inc's management team is headed by:

August Troendle - CHM
Jesse Geiger - CFO
Susan Burwig - EVP
Stephen Ewald - GCN
Robert Kraft - IND
Brian Carley - IND
Bruce Brown - IND
Fred Davenport - LED
Cornelius McCarthy - DRC
Ashley Keating - IND
Thomas King - IND
Who are the major shareholders of Medpace Holdings Inc?

Here are the top five shareholders of Medpace Holdings Inc based on the size of their shareholding:

Medpace Investors, L.L.C. Corporation
Percentage owned: 20.25% (7.17m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 11.61% (4.11m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 10.5% (3.72m shares)
Wasatch Global Investors Inc Investment Advisor/Hedge Fund
Percentage owned: 6.47% (2.29m shares)
iShares Core S&P Small-Cap ETF Mutual Fund
Percentage owned: 4.74% (1.68m shares)
Similar to 01P
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.